Parametrica Management LTD Amicus Therapeutics, Inc. Transaction History

Parametrica Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$9.82 - $12.75 $808,824 - $1.05 Million	-82,365 Reduced 61.3%	51,999 $543,000
Q2 2022 Jul 22, 2022	SELL	$6.23 - $11.12 $2.27 Million - $4.05 Million	-364,042 Reduced 73.04%	134,364 $1.44 Million
Q1 2022 May 10, 2022	SELL	$7.89 - $12.48 $780,107 - $1.23 Million	-98,873 Reduced 16.55%	498,406 $4.72 Million
Q4 2021 Feb 15, 2022	BUY	$9.82 - $12.44 $2,779 - $3,520	283 Added 0.05%	597,279 $6.9 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $849,528 - $1.15 Million	-97,200 Reduced 14.0%	596,996 $5.71 Million
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $750,523 - $923,720	86,168 Added 14.17%	694,196 $6.69 Million
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $5.59 Million - $14.5 Million	608,028 New	608,028 $5.7 Million

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.